MYGN
Myriad Genetics, Inc.

2,106
Mkt Cap
$680.46M
Volume
1.08M
52W High
$15.47
52W Low
$3.76
PE Ratio
-1.66
MYGN Fundamentals
Price
$7.21
Prev Close
$7.30
Open
$7.30
50D MA
$7.39
Beta
1.19
Avg. Volume
1.37M
EPS (Annual)
-$1.41
P/B
1.80
Rev/Employee
$310,222.22
Loading...
Loading...
News
all
press releases
Myriad Genetics, Inc. $MYGN Stake Reduced by Camber Capital Management LP
Camber Capital Management LP decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 14.9% in the 2nd quarter, according to the company in its most recent filing with...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
Prudential Financial Inc. Has $1.82 Million Stock Position in Myriad Genetics, Inc. $MYGN
Prudential Financial Inc. grew its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 95.1% during the second quarter, according to the company in its most recent disclosure with...
MarketBeat·7d ago
News Placeholder
Fisher Asset Management LLC Purchases 219,607 Shares of Myriad Genetics, Inc. $MYGN
Fisher Asset Management LLC lifted its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 20.4% during the 2nd quarter, according to the company in its most recent 13F filing...
MarketBeat·8d ago
News Placeholder
Why Is Exelixis (EXEL) Up 9% Since Last Earnings Report?
Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·9d ago
News Placeholder
Why Is Myriad (MYGN) Up 8.7% Since Last Earnings Report?
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·10d ago
News Placeholder
Myriad Genetics, Inc. $MYGN Stock Holdings Lifted by XTX Topco Ltd
XTX Topco Ltd lifted its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 1,240.7% in the 2nd quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·13d ago
News Placeholder
Jaffetilchin Investment Partners LLC Buys New Shares in Myriad Genetics, Inc. $MYGN
Jaffetilchin Investment Partners LLC purchased a new position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) in the second quarter, according to its most recent filing with the SEC...
MarketBeat·16d ago
News Placeholder
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Recommendation of "Hold" by Analysts
Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) has earned a consensus rating of "Hold" from the sixteen analysts that are presently covering the firm, MarketBeat reports. Two analysts have...
MarketBeat·20d ago
News Placeholder
Myriad Genetics (NASDAQ:MYGN) Trading Up 11.2% - Time to Buy?
Myriad Genetics (NASDAQ:MYGN) Trading Up 11.2% - Here's Why...
MarketBeat·22d ago
News Placeholder
How Did Tempus AI Power Its Move to Positive EBITDA in Q3?
TEM hits its first positive adjusted EBITDA as strong Genomics and Data Licensing growth pairs with tighter cost discipline.
Zacks·26d ago

Latest MYGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.